Once you're in — yes. Text or call anytime. Access itself is application-reviewed, not self-serve overnight.

Will my manager see what I tell Sara?

No. Sara reports to you. Nothing goes up the org chart unless you share it.

Does she record my customer calls?

Never. No bot in the meeting. You reach out after — by text or call.

How is this different from Gong or Chorus?

Gong owns the recorded call — for your manager. Sara owns what happens after you hang up — for you.

Can pharmaceutical sales reps use AI that captures audio of conversations with providers?

Almost never in practice. Recording a conversation with a prescriber raises the same compliance exposure as any other uncontrolled data capture in a clinical setting, on top of the promotional-conduct rules pharma already operates under. The workable version of AI for pharma reps works from what the rep reports afterward, not from an audio capture of the visit itself.

Why do pharma reps already document so much, and how is that different from recording?

Most pharma companies require detailed call notes after every provider interaction — what was discussed, what materials were left, what the prescriber said — logged into a CRM like Veeva for audit and Sunshine Act purposes. That's the rep's own written account, created after the fact. It's a different thing entirely from a third-party tool capturing raw audio of the conversation while it happens.

What should pharma reps look for in an AI sales tool?

Speed of capture, not more surveillance. The visit itself is five minutes in a hallway or a sample closet, and the rep is already required to reconstruct it accurately afterward for compliance. A tool that makes that reconstruction faster and sharper — without adding a recording layer over the conversation — is solving the actual problem instead of adding a new compliance question.

FIELD NOTES

AI for Pharmaceutical Sales Reps: Built for the Five Minutes You Get With a Prescriber

Pharma reps already document every call — Sunshine Act, audit trails, promotional review. What they need isn't more recording. It's faster, cleaner capture.

2026-08-01 · SARA — KEEL'S AI DEAL ASSISTANT · GETKEEL.IO

Elena gets four minutes with Dr. Okafor between patients, standing in the hallway outside exam room three. She mentions the new indication data, he asks one pointed question about a drug interaction, and then he's gone — back in with his next patient before she's finished her sentence. She has until end of day to log the call, accurately, in the CRM her compliance team audits.

Pharma reps already live inside more documentation than almost anyone

It's a common assumption that pharma sales is under-instrumented compared to other B2B motions. The opposite is true. Every provider interaction generates a call note — what was discussed, what samples or materials were left, what the prescriber said — logged for Sunshine Act reporting, internal audit, and promotional-conduct review. Pharma reps have been documenting their calls in detail for longer than "sales AI" has existed as a product category.

So the problem was never a lack of documentation. It's that the documentation happens the hard way: from memory, hours after a hallway conversation that lasted four minutes, competing with the six other provider visits that happened the same day.

Recording the visit doesn't solve this — it adds a second compliance problem

The instinct from a generic sales-AI vendor is to solve documentation with a recorder: attach to the visit, capture the audio, generate the note automatically. That instinct breaks immediately in this vertical. A third-party tool capturing audio of a conversation with a prescriber, in or near a clinical space, is exactly the kind of uncontrolled data capture that hospital and practice compliance offices exist to prevent — on top of the promotional-conduct scrutiny pharma sales already operates under. We've written about why this fails structurally across regulated verticals generally; pharma is one of the sharpest cases of it, because the documentation requirement already exists and doesn't need a recording to satisfy it.

The rep doesn't need a tool that captures the conversation. She needs a tool that captures her account of the conversation, fast, before the next hallway and the next four minutes erase the details of this one.

The real bottleneck is the gap between the visit and the note

Ask any pharma rep where accuracy actually breaks down and it's rarely the visit itself — it's the six or eight hours between the visit and whenever there's finally time to sit down and write the call note. By then, Dr. Okafor's specific question about drug interactions has started blurring into the question a different prescriber asked that morning.

That gap is where detail gets lost or, worse, gets reconstructed generically — a call note that says "discussed efficacy data, prescriber receptive" because the specific exchange didn't survive the day. A compliance function reading that note six months later can't tell the difference between a rep who remembered precisely and one who filled in a template.

What actually helps: capture in the elevator, not at the desk

The fix isn't a better form to fill out at day's end. It's closing the gap between the hallway and the record — talking through what just happened while walking to the car, before the next office, before the detail fades. That's the same logic behind in-person sales meeting AI generally: the tool's job is the moments around the visit, not the visit itself, because nothing should be capturing the visit itself.

For a pharma rep, that means being able to talk through a visit by voice between offices — what the prescriber asked, what got left behind, what follow-up was promised — and have that held accurately until it's time to turn it into the compliance-required note. The rep still writes the record. The tool just stops the four-minute conversation from evaporating before she gets the chance to.

Where Sara fits

Sara doesn't record, transcribe, or capture any conversation with a provider — she works entirely from what the rep tells her afterward, by voice or text, the same way a rep already reconstructs a call note today, just faster and before the detail fades. That's a structural fact about how she's built, not a compliance certification, and any pharma compliance team should verify independently what a vendor does and doesn't capture before adoption.

Built for reps carrying a territory of provider relationships through a day with more five-minute conversations than scheduled meetings. Early access runs through Founders Club, invite-reviewed — apply for early access.

The documentation requirement isn't the problem. The four-minute window is.

Pharma sales was never missing a compliance process — it has one of the most thorough in B2B selling. What it's missing is a way to protect the four minutes in the hallway from getting lost before they turn into the record compliance actually needs.

That's not a recording problem. It's a memory problem, and it's solvable without adding a single new thing for a compliance team to review.

By the team at Keel. We're building Sara, an AI deal assistant for the moments that don't get recorded.

MORE IN THIS SERIES

AI for Financial Services B2B Sales: Selling to a Buyer Who Won't Let You Record the Call

Banks and insurers run every vendor through third-party risk review. A sales AI that captures call audio adds a data-handling question nobody asked for.

Sales AI for Regulated Industries: The Case for Not Recording At All

HIPAA, financial services, pharma — regulated buyers ask what happens to the recording before they ask about price. The fastest answer is having nothing to explain.